Neuraltus Pharmaceuticals' Series A - II Round

Neuraltus Pharmaceuticals raised a round of funding on December 20, 2011.

Neuraltus Pharmaceuticals is a privately-held biopharmaceutical company dedicated to developing and commercializing innovative therapeutics that address critical unmet needs for patients and physician…

Articles about Neuraltus Pharmaceuticals' Series A - II Round: